Mayne Pharma Group Limited (MAYNF)
USD 4.25
(3.41%)
USD 4.25
(3.41%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 388.15 Million | 183.58 Million | 423.91 Million | 400.32 Million | 456.6 Million | 523.95 Million |
| Cost of Revenue | 169.62 Million | 156.74 Million | 253.76 Million | 205.57 Million | 231.48 Million | 222.59 Million |
| Gross Profit | 218.52 Million | 26.83 Million | 170.14 Million | 194.74 Million | 225.11 Million | 301.36 Million |
| Operating Expenses | 264.63 Million | 213.28 Million | 171.69 Million | 173.44 Million | 245.34 Million | 278.91 Million |
| Selling, General and Administrative Expenses | 243.07 Million | 197.55 Million | 75.94 Million | 86.34 Million | 136.02 Million | 158.61 Million |
| Research and Development Expenses | 20.23 Million | 15.72 Million | 14.66 Million | 18.91 Million | 24.75 Million | 25.8 Million |
| Other Expenses | 12.06 Million | 12.62 Million | -7.16 Million | -14.23 Million | 15.44 Million | -7.94 Million |
| Cost and Expenses | 434.25 Million | 370.03 Million | 425.46 Million | 379.01 Million | 476.82 Million | 501.51 Million |
| Operating Income | -45.85 Million | -186.44 Million | 11.31 Million | 7.28 Million | 3.49 Million | 15.44 Million |
| Interest Expense | 34.5 Million | 10.45 Million | 32.09 Million | 32.34 Million | 31.54 Million | 17.44 Million |
| Income Tax Expense | -21.46 Million | 47.74 Million | 56.13 Million | -54.8 Million | -40.83 Million | -69.96 Million |
| Earnings before Tax | -190.08 Million | -269.69 Million | -217.81 Million | -263.88 Million | -135.36 Million | -353.71 Million |
| Net Income | -174.23 Million | -316.41 Million | -263.34 Million | -208.42 Million | -92.78 Million | -280.86 Million |
| Earnings Per Share Basic | -2.05 | -3.85 | -3.20 | -2.65 | -1.21 | -3.81 |
| Earnings Per Share Diluted | -2.12 | -3.67 | -3.20 | -2.65 | -1.21 | -3.81 |
| Weighted Average Shares Outstanding | 82.18 Million | 82.17 Million | 82.29 Million | 78.57 Million | 76.47 Million | 73.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 79.62 Million | 86.26 Million | 82.29 Million | 78.57 Million | 76.47 Million | 73.75 Million |
| Gross Margin | 0.56 | 0.15 | 0.40 | 0.49 | 0.49 | 0.58 |
| EBIT Margin | -0.22 | -0.66 | 0.22 | 0.19 | 0.19 | 0.21 |
| Profit Margin | -0.45 | -1.72 | -0.62 | -0.52 | -0.20 | -0.54 |
| EBITDA | -87.12 Million | -121 Million | -46.34 Million | 75.46 Million | 88.05 Million | 109.94 Million |
| Earnings Before Tax Margin | -0.12 | -1.02 | 0.03 | 0.02 | 0.01 | 0.03 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 388.39 Million | 100.23 Million | 100.23 Million | 187.92 Million | 93.96 Million | 82.42 Million |
| Cost of Revenue | 229.28 Million | 43.74 Million | 43.74 Million | 113.6 Million | 41.07 Million | 38.71 Million |
| Gross Profit | 159.11 Million | 56.49 Million | 56.49 Million | 74.32 Million | 52.89 Million | 43.7 Million |
| Operating Expenses | 236.95 Million | 60.12 Million | 60.12 Million | 113.15 Million | 91.2 Million | 107.88 Million |
| Selling, General and Administrative Expenses | - | 54.8 Million | 54.8 Million | 102.91 Million | 66.73 Million | 100.53 Million |
| Research and Development Expenses | - | 5.32 Million | 5.32 Million | 10.24 Million | 5.45 Million | 7.35 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 466.23 Million | 103.86 Million | 103.86 Million | 226.76 Million | 132.27 Million | 146.6 Million |
| Operating Income | -77.83 Million | -3.62 Million | -3.62 Million | -38.83 Million | -18.96 Million | -64.18 Million |
| Interest Expense | 4.7 Million | 2.4 Million | - | 2.29 Million | - | 3.58 Million |
| Income Tax Expense | -21.46 Million | 8.57 Million | 8.57 Million | -4.31 Million | 2.15 Million | 85.1 Million |
| Earnings before Tax | -190.08 Million | -57.61 Million | -57.61 Million | -74.86 Million | -37.43 Million | -103.16 Million |
| Net Income | -174.23 Million | -51.84 Million | -51.84 Million | -70.55 Million | -35.27 Million | -171.84 Million |
| Earnings Per Share Basic | - | -0.62 | -0.62 | -0.87 | -0.44 | -2.06 |
| Earnings Per Share Diluted | - | -0.66 | -0.66 | -0.87 | -0.44 | -2.06 |
| Weighted Average Shares Outstanding | 79.62 Million | 83.24 Million | 83.24 Million | 81.24 Million | 80.35 Million | 83.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 79.62 Million | 78.88 Million | 78.88 Million | 81.24 Million | 80.35 Million | 83.42 Million |
| Gross Margin | 0.41 | 0.56 | 0.56 | 0.40 | 0.56 | 0.53 |
| EBIT Margin | - | 0.12 | 0.12 | -0.02 | -0.02 | -0.34 |
| Profit Margin | -0.45 | -0.52 | -0.52 | -0.38 | -0.38 | -2.08 |
| EBITDA | - | 11.68 Million | 11.68 Million | -2.95 Million | -2.28 Million | -27.91 Million |
| Earnings Before Tax Margin | -0.20 | -0.04 | -0.04 | -0.21 | -0.20 | -0.78 |
RIGG
UBAAF
GODAVARI
6939
PGD
BRBS